Amplyx Pharmaceuticals Obtains $1,500,000 New Round

  • Feed Type
  • Date
    8/19/2015
  • Company Name
    Amplyx Pharmaceuticals
  • Mailing Address
    3210 Merryfield Row San Diego, CA 92121 USA
  • Company Description
    Amplyx Pharmaceuticals develops improved small molecule drugs.
  • Website
    http://www.amplyx.com
  • Transaction Type
    Debt
  • Transaction Amount
    $1,500,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities.
  • M&A Terms
  • Venture Investor
    Undisclosed

Trending on Xconomy